S 1133 United States Senate · 117th Congress

Cardiovascular Advances in Research and Opportunities Legacy Act

Summary

Cardiovascular Advances in Research and Opportunities Legacy Act This bill expands research on valvular heart disease and its treatment. This disease is caused by damage to or disease affecting any valve that controls blood flow in the heart. The National Institutes of Health must consult with the National Heart, Lung, and Blood Institute to conduct or support research on the disease, including on mitral valve prolapse. This occurs when the valve between the chambers of the left side of the heart seals improperly. The Centers for Disease Control and Prevention (CDC) must develop best practices to treat valvular heart disease. The CDC may also carry out other projects to increase awareness of and reduce deaths from the disease.

Issues: ✓ Healthcare

Bill status in committee 1 of 4 stages cleared

Introduction

Apr 2021

Committee Review

Floor Vote

President

Introduced Apr 15, 2021 Last action Apr 15, 2021

Floor votes

How they voted

No floor votes recorded yet.

Full legislative history

Actions timeline

Total actions

Key actions

Committee

Apr 15, 2021

Committee

Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (Sponsor introductory remarks on measure: CR S1984; text: CR S1985)

upper

Apr 15, 2021

Introduced

Introduced in Senate

upper

1 primary · 2 co-sponsors